Tiny plastic particles called microplastics and nanoplastics are everywhere. A new review looks at how these particles might affect the human body. The study suggests they could trigger inflammation, immune imbalance, and even cancer susceptibility. It also points to cellular stress like apoptosis, ferroptosis, and pyroptosis. These are specific ways cells die or get damaged. The review also notes tissue injury, organelle stress, and genotoxicity. Nuclear entry and chronic immune activation are other concerns. Immune exhaustion is another potential outcome. The study did not report specific safety data or adverse events. It did not report a specific sample size or setting. This review provides a theoretical foundation for future mechanistic investigations and human health risk assessments. We must be careful not to overstate what is known. The evidence is currently theoretical. More research is needed to confirm these risks in real people. Until then, understanding these potential pathways helps us prepare for future health challenges.
Review synthesizes microplastic pollution mechanisms and potential human health risks including inflammation and cancer susceptibilityMicroplastics may trigger inflammation and immune imbalance in the human body
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This narrative review focuses on the theoretical mechanisms associated with microplastic and nanoplastic pollution within the human body. The publication does not report a specific sample size or study setting. Instead, it synthesizes potential biological outcomes including inflammation, immune imbalance, cancer susceptibility, and cellular processes like apoptosis, ferroptosis, pyroptosis, and autophagy. Additional outcomes discussed include tissue injury, organelle stress, genotoxicity, nuclear entry, chronic immune activation, and immune exhaustion.
The review does not report specific adverse events, serious adverse events, discontinuations, or tolerability data. Consequently, the authors do not provide quantitative safety profiles or rates of harm. The text explicitly states that the primary outcome was not reported, and no specific follow-up duration is provided for the synthesized evidence.
The authors acknowledge that this work serves primarily to provide a theoretical foundation for future mechanistic investigations and human health risk assessments. Limitations regarding causality and certainty are not reported in the source text. The review avoids making definitive causal claims about specific clinical interventions or patient populations.